Diabetic nephropathy among Mexican Americans

Subrata Debnath, Farook Thameem, Tahira Alves, Jacqueline Nolen, Al Shahrouri Hania, Shweta Bansal, Hanna E. Abboud, Paolo Fanti

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

The incidence of diabetic nephropathy (DN) is growing rapidly worldwide as a consequence of the rising prevalence of Type 2 diabetes mellitus (T2DM). Among U.S. ethnic groups, Mexican Americans have a disproportionately high incidence and prevalence of DN and associated end-stage renal disease (ESRD). In communities bordering Mexico, as many as 90% of Mexican American patients with ESRD also suffer from T2DM compared to only 50% of non-Hispanic Whites (NHW). Both socio-economic factors and genetic predisposition appear to have a strong influence on this association. In addition, certain pathogenetic and clinical features of T2DM and DN are different in Mexican Americans compared to NHW, raising questions as to whether the diagnostic and treatment strategies that are standard practice in the NHW patient population may not be applicable in Mexican Americans. This article reviews the epidemiology of DN in Mexican Americans, describes the pathophysiology and associated risk factors, and identifies gaps in our knowledge and understanding that needs to be addressed by future investigations.

Original languageEnglish (US)
Pages (from-to)332-344
Number of pages13
JournalClinical Nephrology
Volume77
Issue number4
DOIs
StatePublished - Apr 2012

Fingerprint

Diabetic Nephropathies
Type 2 Diabetes Mellitus
Chronic Kidney Failure
Incidence
Genetic Predisposition to Disease
Mexico
Ethnic Groups
Epidemiology
Economics
Population

Keywords

  • Diabetes
  • Epidemiology
  • Mexican american
  • Nephropathy

ASJC Scopus subject areas

  • Nephrology

Cite this

Debnath, S., Thameem, F., Alves, T., Nolen, J., Hania, A. S., Bansal, S., ... Fanti, P. (2012). Diabetic nephropathy among Mexican Americans. Clinical Nephrology, 77(4), 332-344. https://doi.org/10.5414/CN107487

Diabetic nephropathy among Mexican Americans. / Debnath, Subrata; Thameem, Farook; Alves, Tahira; Nolen, Jacqueline; Hania, Al Shahrouri; Bansal, Shweta; Abboud, Hanna E.; Fanti, Paolo.

In: Clinical Nephrology, Vol. 77, No. 4, 04.2012, p. 332-344.

Research output: Contribution to journalArticle

Debnath, S, Thameem, F, Alves, T, Nolen, J, Hania, AS, Bansal, S, Abboud, HE & Fanti, P 2012, 'Diabetic nephropathy among Mexican Americans', Clinical Nephrology, vol. 77, no. 4, pp. 332-344. https://doi.org/10.5414/CN107487
Debnath S, Thameem F, Alves T, Nolen J, Hania AS, Bansal S et al. Diabetic nephropathy among Mexican Americans. Clinical Nephrology. 2012 Apr;77(4):332-344. https://doi.org/10.5414/CN107487
Debnath, Subrata ; Thameem, Farook ; Alves, Tahira ; Nolen, Jacqueline ; Hania, Al Shahrouri ; Bansal, Shweta ; Abboud, Hanna E. ; Fanti, Paolo. / Diabetic nephropathy among Mexican Americans. In: Clinical Nephrology. 2012 ; Vol. 77, No. 4. pp. 332-344.
@article{d321e4781eec40648584aeb14ea16abe,
title = "Diabetic nephropathy among Mexican Americans",
abstract = "The incidence of diabetic nephropathy (DN) is growing rapidly worldwide as a consequence of the rising prevalence of Type 2 diabetes mellitus (T2DM). Among U.S. ethnic groups, Mexican Americans have a disproportionately high incidence and prevalence of DN and associated end-stage renal disease (ESRD). In communities bordering Mexico, as many as 90{\%} of Mexican American patients with ESRD also suffer from T2DM compared to only 50{\%} of non-Hispanic Whites (NHW). Both socio-economic factors and genetic predisposition appear to have a strong influence on this association. In addition, certain pathogenetic and clinical features of T2DM and DN are different in Mexican Americans compared to NHW, raising questions as to whether the diagnostic and treatment strategies that are standard practice in the NHW patient population may not be applicable in Mexican Americans. This article reviews the epidemiology of DN in Mexican Americans, describes the pathophysiology and associated risk factors, and identifies gaps in our knowledge and understanding that needs to be addressed by future investigations.",
keywords = "Diabetes, Epidemiology, Mexican american, Nephropathy",
author = "Subrata Debnath and Farook Thameem and Tahira Alves and Jacqueline Nolen and Hania, {Al Shahrouri} and Shweta Bansal and Abboud, {Hanna E.} and Paolo Fanti",
year = "2012",
month = "4",
doi = "10.5414/CN107487",
language = "English (US)",
volume = "77",
pages = "332--344",
journal = "Clinical Nephrology",
issn = "0301-0430",
publisher = "Dustri-Verlag Dr. Karl Feistle",
number = "4",

}

TY - JOUR

T1 - Diabetic nephropathy among Mexican Americans

AU - Debnath, Subrata

AU - Thameem, Farook

AU - Alves, Tahira

AU - Nolen, Jacqueline

AU - Hania, Al Shahrouri

AU - Bansal, Shweta

AU - Abboud, Hanna E.

AU - Fanti, Paolo

PY - 2012/4

Y1 - 2012/4

N2 - The incidence of diabetic nephropathy (DN) is growing rapidly worldwide as a consequence of the rising prevalence of Type 2 diabetes mellitus (T2DM). Among U.S. ethnic groups, Mexican Americans have a disproportionately high incidence and prevalence of DN and associated end-stage renal disease (ESRD). In communities bordering Mexico, as many as 90% of Mexican American patients with ESRD also suffer from T2DM compared to only 50% of non-Hispanic Whites (NHW). Both socio-economic factors and genetic predisposition appear to have a strong influence on this association. In addition, certain pathogenetic and clinical features of T2DM and DN are different in Mexican Americans compared to NHW, raising questions as to whether the diagnostic and treatment strategies that are standard practice in the NHW patient population may not be applicable in Mexican Americans. This article reviews the epidemiology of DN in Mexican Americans, describes the pathophysiology and associated risk factors, and identifies gaps in our knowledge and understanding that needs to be addressed by future investigations.

AB - The incidence of diabetic nephropathy (DN) is growing rapidly worldwide as a consequence of the rising prevalence of Type 2 diabetes mellitus (T2DM). Among U.S. ethnic groups, Mexican Americans have a disproportionately high incidence and prevalence of DN and associated end-stage renal disease (ESRD). In communities bordering Mexico, as many as 90% of Mexican American patients with ESRD also suffer from T2DM compared to only 50% of non-Hispanic Whites (NHW). Both socio-economic factors and genetic predisposition appear to have a strong influence on this association. In addition, certain pathogenetic and clinical features of T2DM and DN are different in Mexican Americans compared to NHW, raising questions as to whether the diagnostic and treatment strategies that are standard practice in the NHW patient population may not be applicable in Mexican Americans. This article reviews the epidemiology of DN in Mexican Americans, describes the pathophysiology and associated risk factors, and identifies gaps in our knowledge and understanding that needs to be addressed by future investigations.

KW - Diabetes

KW - Epidemiology

KW - Mexican american

KW - Nephropathy

UR - http://www.scopus.com/inward/record.url?scp=84861494927&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84861494927&partnerID=8YFLogxK

U2 - 10.5414/CN107487

DO - 10.5414/CN107487

M3 - Article

C2 - 22445478

AN - SCOPUS:84861494927

VL - 77

SP - 332

EP - 344

JO - Clinical Nephrology

JF - Clinical Nephrology

SN - 0301-0430

IS - 4

ER -